Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Senate debates extension and tighter definition for cannabidiol program
Summary
Senators discussed House Bill 58 to extend Utah's cannabidiol program to 2021, direct a study by the Department of Health, and narrow the statute's CBD concentration threshold from 15% to 5%; proponents cited family‑level benefits in limited pilots.
SALT LAKE CITY — House Bill 58, a measure amending Utah's cannabidiol provisions, was presented to the Senate with the sponsor outlining three changes: extending the program's sunset to 2021, directing the Department of Health to conduct a study and narrowing the statutory CBD definition.
Senator Urquhart, the sponsor, told the Senate the bill "extends the sunset date to 2021," instructs the Department of Health to conduct a study, and "lowers the amount of CBD from 15% to 5 percent." He described the 2014 pilot that allowed access for patients with intractable epilepsy and characterized cannabidiol as a "non‑psychotropic cannabinoid."
An unnamed commenter spoke in favor of keeping the program, citing families helped and reporting that roughly "55% of those families" experienced substantial benefit in early participation. The sponsor waived summation and moved HB58 for third reading; the clerk began a roll call but the excerpt ends before a final tally is reported.
Next steps: The roll call for third reading was initiated on the floor; the transcript excerpt does not include a final vote count or outcome.
